This application requests funding for a CCSG grant for the University of Colorado Cancer Center (UCCC) for years 09-13. The University of Colorado Cancer Center is a """"""""Center"""""""" within the School of medicine at the University of Colorado Health Sciences Center. The Cancer Center goals are; 1) to contribute through coordinated research, clinical, prevention and control and educational activities effort to the eventual elimination of cancer as a human health problem, and 2) to provide the citizens of the State of Colorado and the Rocky Mountains region with state of the art cancer research, therapy, prevention, control and educational programs. The Cancer Center serves more than 6 million people in Colorado and the 7 surrounding states in the Rocky Mountain region. The over 280 Cancer Center members have more than $48 million (annual direct costs) in peer- reviewed grants an contracts relating to the cancer problem. Cancer Center members provide care to 15-20% of the cancer population in the region and enter more than 1,600 patients on cancer clinical trials each year. The Cancer Center enters an increasing number of patients of clinical trials emphasizing novel trials of the Center and high priority trials of the National Cancer Institute. The majority of cancer educational, prevention and control programs in the region are organized by Cancer Center members. The Center provides the major centralized support for these functions through its 11 shared """"""""core"""""""" facilities in Biostatistics, Clinical Investigations, Cytogenetics, Fermentation, Flow Cytometry, Histopathology/Tissue Procurement, Laboratory Animals/Transgenic Animals, Macromolecular Resources, Radiological Sciences, Immunology and Tissue Culture/Monoclonal Antibodies. The Cancer Center has 14 institutional members including the Health Sciences Center schools, affiliated hospitals and other institutions with a primary focus in cancer. The chief executive officers of these organizations form the Cancer Center Board which assures coordination of the cancer effort in the region. The Cancer Center has four major program divisions: Basic Research, Clinical Activities, Education and prevention and Control and is developing a Community Research Division. The Basic Research Division is divided into: Immunology; Molecular Biology; Growth Regulation; Cell Surface; Hormones an Cancer; Chromosomes and Mutation. The Clinical Division is divided into: Adult Clinical Oncology, Breast Cancer, Lung Cancer and Pediatric oncology; and the Prevention and Control Division is divided into Causation and Clinical Prevention and Control programs. The UCCC is currently an NCI designated """"""""Clinical Cancer Center"""""""". Our plans are to seek approval as an """"""""NCI Comprehensive Cancer Center"""""""" during the next funding cycle.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA046934-13
Application #
6150077
Study Section
Cancer Centers and Research Programs Review Committee (CCRP)
Program Officer
Ciolino, Henry P
Project Start
1988-03-01
Project End
2001-01-31
Budget Start
2000-03-01
Budget End
2001-01-31
Support Year
13
Fiscal Year
2000
Total Cost
$2,788,272
Indirect Cost
Name
University of Colorado Denver
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Maccini, Michael A; Westfall, Nicholas J; Van Bokhoven, Adrie et al. (2018) The effect of digital rectal exam on the 4Kscore for aggressive prostate cancer. Prostate 78:506-511
Ye, Haobin; Adane, Biniam; Khan, Nabilah et al. (2018) Subversion of Systemic Glucose Metabolism as a Mechanism to Support the Growth of Leukemia Cells. Cancer Cell 34:659-673.e6
Flannery, Patrick C; DeSisto, John A; Amani, Vladimir et al. (2018) Preclinical analysis of MTOR complex 1/2 inhibition in diffuse intrinsic pontine glioma. Oncol Rep 39:455-464
Elder, Alan M; Tamburini, Beth A J; Crump, Lyndsey S et al. (2018) Semaphorin 7A Promotes Macrophage-Mediated Lymphatic Remodeling during Postpartum Mammary Gland Involution and in Breast Cancer. Cancer Res 78:6473-6485
Yue, Zongliang; Zheng, Qi; Neylon, Michael T et al. (2018) PAGER 2.0: an update to the pathway, annotated-list and gene-signature electronic repository for Human Network Biology. Nucleic Acids Res 46:D668-D676
Smith, Weston J; Tran, Huy; Griffin, James I et al. (2018) Lipophilic indocarbocyanine conjugates for efficient incorporation of enzymes, antibodies and small molecules into biological membranes. Biomaterials 161:57-68
Morgan, Michael J; Fitzwalter, Brent E; Owens, Charles R et al. (2018) Metastatic cells are preferentially vulnerable to lysosomal inhibition. Proc Natl Acad Sci U S A 115:E8479-E8488
Hartwick, Erik W; Costantino, David A; MacFadden, Andrea et al. (2018) Ribosome-induced RNA conformational changes in a viral 3'-UTR sense and regulate translation levels. Nat Commun 9:5074
Genova, Carlo; Socinski, Mark A; Hozak, Rebecca R et al. (2018) EGFR Gene Copy Number by FISH May Predict Outcome of Necitumumab in Squamous Lung Carcinomas: Analysis from the SQUIRE Study. J Thorac Oncol 13:228-236
Greer, Robert O; Eskendri, Jeffrey; Freedman, Paul et al. (2018) Assessment of biologically aggressive, recurrent glandular odontogenic cysts for mastermind-like 2 (MAML2) rearrangements: histopathologic and fluorescent in situ hybridization (FISH) findings in 11 cases. J Oral Pathol Med 47:192-197

Showing the most recent 10 out of 1634 publications